Association of ketotifen use with cutaneous and neural tumor diagnoses in neurofibromatosis type 1
Clicks: 1
ID: 315944
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
0.0
/100
1 views
0 readers
AI Quality Assessment
Not analyzed
Readership in this journal
Ranked #179 of 302 articles by views in the british journal of dermatology
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 302 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Long-term ketotifen use was associated with a significantly lower incidence of recorded diagnoses of benign cutaneous tumours among patients with neurofibromatosis type 1. No statistically significant association was observed for neural tumours. These findings suggest that ketotifen may be a potentially accessible adjunctive option in the management of benign cutaneous tumours in neurofibromatosis type 1.
| Reference Key |
openalex_W7163365068
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Minsu Kim, Suhyun Han, Chong Won Choi, Sang Woong Youn, Bo Ri Kim |
| Journal | the british journal of dermatology |
| Year | 2026 |
| DOI |
10.1093/bjd/ljag225
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.